ZA200800567B - Compounds for treatment of lipase-mediated diseases - Google Patents
Compounds for treatment of lipase-mediated diseasesInfo
- Publication number
- ZA200800567B ZA200800567B ZA200800567A ZA200800567A ZA200800567B ZA 200800567 B ZA200800567 B ZA 200800567B ZA 200800567 A ZA200800567 A ZA 200800567A ZA 200800567 A ZA200800567 A ZA 200800567A ZA 200800567 B ZA200800567 B ZA 200800567B
- Authority
- ZA
- South Africa
- Prior art keywords
- lipase
- compounds
- treatment
- mediated diseases
- mediated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C50/00—Quinones
- C07C50/02—Quinones with monocyclic quinoid structure
- C07C50/04—Benzoquinones, i.e. C6H4O2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/78—Benzoic acid esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
- C07C69/92—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN864MU2005 | 2005-07-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200800567B true ZA200800567B (en) | 2008-11-26 |
Family
ID=36121552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200800567A ZA200800567B (en) | 2005-07-21 | 2008-01-18 | Compounds for treatment of lipase-mediated diseases |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1937622A1 (xx) |
JP (1) | JP2009505953A (xx) |
KR (1) | KR100928954B1 (xx) |
CN (1) | CN101228108A (xx) |
AU (1) | AU2005334672A1 (xx) |
BR (1) | BRPI0520515A2 (xx) |
CA (1) | CA2614585A1 (xx) |
IL (1) | IL188894A0 (xx) |
NZ (1) | NZ565878A (xx) |
RU (1) | RU2420513C2 (xx) |
WO (1) | WO2007010546A1 (xx) |
ZA (1) | ZA200800567B (xx) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9623021B2 (en) * | 2007-01-22 | 2017-04-18 | Gtx, Inc. | Nuclear receptor binding agents |
AU2014230640B2 (en) * | 2013-03-14 | 2018-08-16 | Shionogi & Co., Ltd. | Monoclonal antibody inhibiting enzymatic activity of endothelial lipase |
JP2016534049A (ja) * | 2013-10-08 | 2016-11-04 | テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイションTemple University−Of The Commonwealth System Of Higher Education | 内皮リパーゼ阻害を示す官能基化フラン−2−スルホンアミド |
US10259804B2 (en) | 2014-09-26 | 2019-04-16 | Shifa Biomedical Corporation | Anti-endothelial lipase compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseases |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7510536A (en) * | 1975-09-05 | 1977-03-08 | Council Scient Ind Res | Salts of embelin with primary amines |
DE2540282A1 (de) * | 1975-09-10 | 1977-03-24 | Council Scient Ind Res | Kondensationsprodukt von embelin mit einem primaeren amin und verfahren zu seiner herstellung |
US20010047032A1 (en) * | 1999-12-30 | 2001-11-29 | Castillo Gerardo M. | Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases |
-
2005
- 2005-09-19 WO PCT/IN2005/000318 patent/WO2007010546A1/en active Application Filing
- 2005-09-19 BR BRPI0520515-8A patent/BRPI0520515A2/pt not_active IP Right Cessation
- 2005-09-19 AU AU2005334672A patent/AU2005334672A1/en not_active Abandoned
- 2005-09-19 EP EP05823794A patent/EP1937622A1/en not_active Withdrawn
- 2005-09-19 CN CNA2005800511311A patent/CN101228108A/zh active Pending
- 2005-09-19 RU RU2008106628/04A patent/RU2420513C2/ru not_active IP Right Cessation
- 2005-09-19 CA CA002614585A patent/CA2614585A1/en not_active Abandoned
- 2005-09-19 KR KR1020087001911A patent/KR100928954B1/ko not_active IP Right Cessation
- 2005-09-19 NZ NZ565878A patent/NZ565878A/en not_active IP Right Cessation
- 2005-09-19 JP JP2008522176A patent/JP2009505953A/ja active Pending
-
2008
- 2008-01-18 ZA ZA200800567A patent/ZA200800567B/xx unknown
- 2008-01-20 IL IL188894A patent/IL188894A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
NZ565878A (en) | 2010-04-30 |
JP2009505953A (ja) | 2009-02-12 |
RU2420513C2 (ru) | 2011-06-10 |
CN101228108A (zh) | 2008-07-23 |
RU2008106628A (ru) | 2009-08-27 |
KR20080030044A (ko) | 2008-04-03 |
BRPI0520515A2 (pt) | 2009-05-12 |
AU2005334672A1 (en) | 2007-01-25 |
KR100928954B1 (ko) | 2009-11-30 |
EP1937622A1 (en) | 2008-07-02 |
CA2614585A1 (en) | 2007-01-25 |
WO2007010546A1 (en) | 2007-01-25 |
IL188894A0 (en) | 2008-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL194076A0 (en) | Imidazolothiazole compounds for the treatment of disease | |
IL195571A0 (en) | Compounds for the treatment of periodontal disease | |
IL187739A0 (en) | New 2-azetidinone derivatives for the treatment of hyperlipidaemic diseases | |
ZA200800907B (en) | Treatment of cancer | |
IL186578A0 (en) | Compositions for treatment of neovascularization diseases | |
EP2004204A4 (en) | TREATMENT OF NEURODEGENERATIVE DISEASES | |
IL190779A0 (en) | Compositions for treatment of eye diseases | |
EP1962869A4 (en) | TREATMENT OF RESPIRATORY DISEASES | |
EP1987838A4 (en) | NEW CONNECTION TO TUMOR THERAPY | |
IL187715A0 (en) | Use of phenylsemicarbazones for seed treatment | |
GB0610183D0 (en) | Treatment of neurodegenerative diseases | |
GB0518508D0 (en) | Treatment of waste | |
EP1867640A4 (en) | MEANS FOR TREATING SOLID TUMORS | |
GB0605715D0 (en) | Treatment of laminitis | |
IL186904A0 (en) | Novel compounds for treating inflammatory diseases | |
EP1963358A4 (en) | TREATMENT OF DISEASES ASSOCIATED WITH THE EPSTEIN-BARR-VIRUS | |
EP1986656A4 (en) | WITHACNISTINE COMPOUNDS FOR THE TREATMENT OF CANCER | |
IL188894A0 (en) | Compounds for treatment of lipase-mediated diseases | |
GB0400802D0 (en) | Compounds for the treatment of disease | |
GB0520067D0 (en) | Treatment of cancer | |
ZA200707592B (en) | Novel compounds for treating inflammatory diseases | |
IL190182A0 (en) | 2-aminoalcohols for the treatment of neurodegenerative diseases | |
ZA200606780B (en) | Compounds for the treatment of diseases | |
GB0623740D0 (en) | Treatment of disease | |
HU0500947D0 (en) | Composition for treatment of paradontosis |